Intevac Announces Record Order for ENERGi™ Solar Implant Systems
Mon, March 13 2017
Follow-on Order for 12 Systems for High-Efficiency Solar Cells
“The industry is beginning its transition to higher-efficiency solar
cells, which reduce the Levelized Cost of Electricity (LCOE),” commented
“Our customer’s capacity expansion of high-efficiency bi-facial solar
cells incorporates our ion implant source technology as a key enabler in
achieving higher-efficiency N-type solar cells,” said
The first two ENERGi systems were ordered in the second quarter
of last year and shipped in the second half of 2016. The 12 follow-on
systems are scheduled to ship in the second half of 2017, with revenue
recognition dependent on the timing of customer sign-off. Company
management will provide an update to fiscal 2017 revenue guidance during
its first-quarter results conference call scheduled for
About the ENERGi™
Intevac’s ENERGi™ ion implant system, designed specifically for c-Si solar cell manufacturing, brings all the benefits of increased productivity, high throughput, maximum efficiency and lower cost to the solar industry. ENERGi serves today’s critical requirements and is extendible to meet the ongoing technology advancement of cell performance.
ENERGi™ is a registered trademark of
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
Forward-Looking Statements
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
View source version on businesswire.com: http://www.businesswire.com/news/home/20170313005311/en/
Chief Financial Officer
or
Investor Relations
Source: